封面
市场调查报告书
商品编码
1441177

全球 MRI 导引神经外科消融市场规模、份额、成长分析、按产品、最终用途 - 产业预测 2023-2030

Global MRI-Guided Neurosurgical Ablation Market Size, Share, Growth Analysis, By Product(MRI Guided RF Ablation Systems, MRI Guided Laser Ablation Systems), By End-use(Hospitals, Clinics and Ambulatory Surgical Centers) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球MRI导引神经外科消融市场规模估值为6.0831亿美元,从2023年的6.5271亿美元成长到2031年的11.4688亿美元,预测期间(2024-2031年)复合年增长率预计为7.3% ) 。

全球 MRI 导引神经外科消融市场在更广泛的医疗技术领域中占据重要地位,为神经系统疾病的精准微创治疗提供创新解决方案。该市场包括各种先进技术和设备,旨在利用磁振造影(MRI)来指导大脑内的外科消融手术。这些手术主要旨在治疗需要切除目标组织的神经系统疾病,例如脑肿瘤、癫痫和帕金森氏症。从商业角度来看,MRI引导的神经外科消融市场对于医疗设备和医疗保健产业的公司来说代表着巨大的机会。随着全球神经系统疾病盛行率的增加以及对微创治疗方案的需求增加,人们越来越需要先进的技术来改善患者的治疗结果,同时减少手术风险和恢復时间。因此,MRI 引导神经外科消融系统的製造商和开发人员对其产品和服务的需求激增。推动市场成长的主要因素之一是最尖端科技的不断创新和发展,以提高神经外科手术的精确度、准确性和安全性。投资研发的公司正在部署下一代 MRI 引导消融系统,该系统具有先进的影像处理功能、机器人辅助和即时监控功能。这些技术进步不仅使医疗保健专业人员能够更可靠、更有效率地执行复杂的手术,而且有助于改善患者的治疗结果和满意度。

此外,由于住院时间更短、术后併发症更少和患者康復时间更快等因素,该市场也受益于神经外科越来越多地采用微创技术。与传统手术方法相比,MRI 引导消融具有明显的优势,因为它可以精确定位病变组织,同时最大限度地减少对周围健康结构的损害。这导致了向微创治疗方法的转变,并增加了对 MRI 导引神经外科消融系统的需求。除了技术创新和治疗模式的转变之外,市场成长还受到医疗保健支出增加、对神经系统疾病的认识提高以及患者数量增加等因素的影响,尤其是在新兴国家。然而,高昂的初始成本、报销问题和监管限制等挑战可能会阻碍市场扩张,产业参与者必须采取策略措施来有效解决这些障碍。

目录

执行摘要

  • 市场概况
  • 命运之轮

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模估算
  • 市场假设与限制

母市场分析

  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • Start-Ups分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 监管形势
  • 波特的分析
  • 对未来中断的特殊考虑

全球 MRI 导引神经外科消融市场:按产品

  • 市场概况
  • MRI导引射频消融系统
  • MRI导引雷射消熔系统
  • MRI 导引聚焦超音波系统和配件

全球 MRI 导引神经外科消融市场:依最终用途分类

  • 市场概况
  • 医院
  • 诊所及门诊手术中心

全球 MRI 导引神经外科消融市场规模(按地区)

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争形势

  • 5大公司比较
  • 主要企业市场定位(2021年)
  • 主要市场参与者所采取的策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率(2021年)

主要企业简介

  • Medtronic
  • InSightec Ltd.
  • Elekta AB
  • Monteris Medical
  • Profound Medical
  • Boston Scientific Corporation
  • MR Solutions
  • MRI Interventions, Inc.
  • Varian Medical Systems
  • AngioDynamics
  • Abbott Laboratories
  • Hitachi Medical Systems
  • Siemens Healthineers
  • IMRIS, Deerfield Imaging
  • Accuray Incorporated
  • Perseon Corporation
  • Elekta AB
  • Isacord
  • Monteris Medical
  • Focal Therapeutics
  • Shamrad Electronics
简介目录
Product Code: SQMIG35H2181

Global MRI-Guided Neurosurgical Ablation Market size was valued at USD 608.31 million in 2022 and is poised to grow from USD 652.71 million in 2023 to USD 1146.88 million by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).

The global MRI-guided neurosurgical ablation market represents a crucial segment within the broader medical technology landscape, offering innovative solutions for precise and minimally invasive treatment of neurological disorders. This market encompasses a range of advanced technologies and devices designed to utilize magnetic resonance imaging (MRI) for guiding surgical ablation procedures in the brain. These procedures are primarily aimed at treating conditions such as brain tumors, epilepsy, Parkinson's disease, and other neurological disorders that may require targeted tissue ablation. From a business perspective, the MRI-guided neurosurgical ablation market presents significant opportunities for companies operating in the medical device and healthcare sectors. With the increasing prevalence of neurological disorders globally and growing demand for minimally invasive treatment options, there is a rising need for advanced technologies that can improve patient outcomes while reducing procedural risks and recovery times. As a result, manufacturers and developers of MRI-guided neurosurgical ablation systems are witnessing a surge in demand for their products and services. One of the key drivers propelling market growth is the continuous innovation and development of cutting-edge technologies that enhance the precision, accuracy, and safety of neurosurgical procedures. Companies investing in research and development are introducing next-generation MRI-guided ablation systems equipped with advanced imaging capabilities, robotic assistance, and real-time monitoring features. These technological advancements not only empower healthcare professionals to perform complex procedures with greater confidence and efficiency but also contribute to better patient outcomes and satisfaction.

Moreover, the market is benefiting from the growing adoption of minimally invasive techniques in neurosurgery, driven by factors such as shorter hospital stays, reduced post-operative complications, and faster recovery times for patients. MRI-guided ablation offers distinct advantages over traditional surgical approaches by enabling precise targeting of diseased tissue while minimizing damage to surrounding healthy structures. This has led to a shift towards less invasive treatment modalities, thereby fueling the demand for MRI-guided neurosurgical ablation systems. In addition to technological innovation and shifting treatment paradigms, market growth is also influenced by factors such as increasing healthcare expenditure, rising awareness about neurological disorders, and expanding patient populations, particularly in emerging economies. However, challenges such as high initial costs, reimbursement issues, and regulatory constraints may pose obstacles to market expansion, necessitating strategic initiatives by industry players to address these barriers effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MRI-Guided Neurosurgical Ablation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MRI-Guided Neurosurgical Ablation Market Segmental Analysis

Global MRI-guided neurosurgical ablation market is segmented on the basis of technology, end use and region. By Technology, the market is segmented into MRI guided RF ablation systems, MRI guided laser ablation systems, MRI guided focused ultrasound systems and accessories. By end use, the market is segmented into Hospitals, Clinics and Ambulatory surgical centers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global MRI-Guided Neurosurgical Ablation Market

The global MRI-guided neurosurgical ablation market has experienced significant growth in recent years, driven by several factors including technological advancements, increasing prevalence of neurological disorders, and rising demand for minimally invasive surgical procedures. One key market driver is the growing adoption of MRI-guided neurosurgical ablation techniques due to their ability to provide real-time imaging, precise targeting, and enhanced safety compared to traditional surgical methods. MRI-guided procedures allow surgeons to visualize the target tissue and surrounding structures with high resolution, enabling accurate placement of the ablation probe and minimizing damage to healthy brain tissue. This has led to improved patient outcomes, reduced complications, and shorter recovery times, driving the demand for MRI-guided neurosurgical ablation systems globally.

Restraints in the Global MRI-Guided Neurosurgical Ablation Market

However, despite the numerous advantages, the market also faces certain restraints that could hinder its growth trajectory. One notable restraint is the high cost associated with MRI-guided neurosurgical ablation procedures and equipment. The initial capital investment required for setting up MRI-guided surgical suites and purchasing specialized equipment can be substantial, limiting accessibility for healthcare facilities, particularly in emerging economies with constrained healthcare budgets. Moreover, reimbursement challenges and regulatory hurdles may further impede market expansion, particularly in regions where healthcare reimbursement policies are stringent or uncertain. Addressing these cost-related barriers and enhancing reimbursement frameworks will be crucial for broader adoption of MRI-guided neurosurgical ablation technologies worldwide.

Market Trends of the Global MRI-Guided Neurosurgical Ablation Market

In terms of trends, one prominent development in the MRI-guided neurosurgical ablation market is the ongoing innovation and development of advanced ablation techniques and platforms. Manufacturers are increasingly focusing on improving the precision, efficiency, and safety of neurosurgical ablation procedures through technological innovations such as real-time temperature monitoring, automated planning software, and integrated navigation systems. Additionally, there is a growing trend towards the integration of MRI-guided ablation systems with other imaging modalities, such as positron emission tomography (PET) or computed tomography (CT), to enhance the accuracy of targeting and treatment planning. These advancements are expected to drive further adoption of MRI-guided neurosurgical ablation techniques and expand their applications in treating various neurological conditions, including brain tumors, epilepsy, and movement disorders, thus fueling market growth in the coming years.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global MRI-Guided Neurosurgical Ablation Market by Product

  • Market Overview
  • MRI Guided RF Ablation Systems
  • MRI Guided Laser Ablation Systems
  • MRI Guided Focused Ultrasound Systems and Accessories

Global MRI-Guided Neurosurgical Ablation Market by End-use

  • Market Overview
  • Hospitals
  • Clinics and Ambulatory Surgical Centers

Global MRI-Guided Neurosurgical Ablation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InSightec Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monteris Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Profound Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MR Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MRI Interventions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Varian Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IMRIS, Deerfield Imaging
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accuray Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perseon Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Isacord
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monteris Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Focal Therapeutics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shamrad Electronics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments